MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

31.77 7.95

Buy Sell

Overview

Share price change

24h

Current

Min

28.86

Max

34.64

Key metrics
By Trading Economics
Income	-28M 22M
Sales	4.3M 244M
P/E Sector Avg	10.897 60.328
Profit margin	9.224
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+39.69% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	161M 1.7B
Previous open	23.82
Previous close	31.77

News Sentiment

By Acuity

25%

75%

72 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 kwi 2026, 23:27 UTC

Major News Events

BHP Expects Annual Copper Output in Upper Half of Guidance, Finishes China Iron-Ore Negotiations

21 kwi 2026, 23:27 UTC

Hot Stocks

Stocks to Watch: Sonoco Products, Adobe, Manhattan Associates, Target Hospitality

21 kwi 2026, 23:02 UTC

Earnings

Correction to Capital One Financial 1Q Earnings Article

21 kwi 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 kwi 2026, 23:47 UTC

Market Talk

Nikkei May Decline as Hopes for U.S.-Iran Peace Talks Fade

21 kwi 2026, 23:36 UTC

Market Talk

Major News Events

Market Talk Roundup: Latest on U.S. Politics

21 kwi 2026, 23:36 UTC

Market Talk

Major News Events

Gold Edges Higher After Trump Says U.S. Will Extend Cease-Fire Deadline -- Market Talk

21 kwi 2026, 23:32 UTC

Earnings

America Movil 1Q EBITDA MXN94.5B, Up 3.8% on Year >AMX

21 kwi 2026, 23:30 UTC

Earnings

America Movil 1Q Rev MXN236.84B, Up 2.1% on Year >AMX

21 kwi 2026, 23:28 UTC

Earnings

America Movil 1Q Net MXN23.4B Vs. Net MXN18.7B >AMX

21 kwi 2026, 23:16 UTC

Major News Events

Ampol Entered 2Q With Hedge Book Positioned to Mitigate Volatility

21 kwi 2026, 23:15 UTC

Major News Events

Ampol Entered 2Q With Broad-Based Momentum

21 kwi 2026, 23:15 UTC

Major News Events

Ampol: Suitable Crudes for Lytton Remain Available in Market

21 kwi 2026, 23:14 UTC

Major News Events

Ampol: Crude Supplies Secured Into July

21 kwi 2026, 23:14 UTC

Major News Events

Ampol: Fuel Supplies Secured Until at Least End of May

21 kwi 2026, 23:13 UTC

Major News Events

Ampol: Well Placed for Crude, Product Supply Prior to Iran Conflict

21 kwi 2026, 23:13 UTC

Major News Events

Ampol 1Q Lytton Refinery Production 1.43 Billion Liters

21 kwi 2026, 23:12 UTC

Major News Events

Ampol 1Q Lytton Refiner Margin US$25.45/Bbl

21 kwi 2026, 22:54 UTC

Market Talk

Sell America Trade Could Gain Momentum If Fed Uncertainty Unresolved -- Market Talk

21 kwi 2026, 22:49 UTC

Major News Events

BHP 3Q Average Realized Energy Coal Price $105.61/Ton, Up 10% On-Quarter

21 kwi 2026, 22:49 UTC

Major News Events

BHP 3Q Average Realized Steelmaking Coal Price $226.76/Ton, Up 15% On-Quarter

21 kwi 2026, 22:48 UTC

Major News Events

BHP 3Q Average Realized Iron Ore Price $85.35/Ton, Flat On-Quarter

21 kwi 2026, 22:48 UTC

Acquisitions, Mergers, Takeovers

Alliance Portfolio Is Comprised of Five Plants: Batavia, Hillburn, Massena, Shoemaker and Sterling

21 kwi 2026, 22:48 UTC

Major News Events

BHP 3Q Average Realized Copper Price $5.86/Pound, Down 1% On-Quarter

21 kwi 2026, 22:48 UTC

Acquisitions, Mergers, Takeovers

PowerTransitions to Buy 323 MW of Power Generation Assets in New York State From Alliance Energy Group

21 kwi 2026, 22:46 UTC

Major News Events

BHP: Has Concluded Iron Ore Sales Contract Negotiations With China Mineral Resources Group

21 kwi 2026, 22:45 UTC

Major News Events

BHP: Pampa Norte Production Down on Ore Complexity, Variation; Declining Grades

21 kwi 2026, 22:45 UTC

Major News Events

BHP: Escondida Concentrator Investment Estimated Between $4.4 Billion-$5.9 Billion

21 kwi 2026, 22:44 UTC

Major News Events

BHP: Escondida Concentrator Project Seen Facing FID in 2027-28

21 kwi 2026, 22:42 UTC

Major News Events

BHP CEO: Centralized Procurement, Low-cost Operations Help Buffer Industry Wide Cost Pressures

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

39.69% upside

12 Months Forecast

Average 41.25 USD 39.69%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

72 / 348 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.